Phase I/II Study of Nelfinavir in Liposarcoma.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Nelfinavir (Primary)
- Indications Liposarcoma
- Focus Adverse reactions; Therapeutic Use
- 01 Apr 2015 Biomarkers information updated
- 01 Jul 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 23 Mar 2012 Planned end date changed from 1 Mar 2012 to 1 Mar 2013 as reported by ClinicalTrials.gov.